US Stock
Closed Market
AbCellera Stock
•ABCLClosed Market
$3,59
$0(0,28%)Past Day
+$0,05(1,70%)After Hours
About AbCellera
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 562 full-time employees. The company went IPO on 2020-12-11. Read moreSectorHealth Care
IndustryPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ NMS - GLOBAL MARKET
Employees562
HeadquarterVancouver, United States
Websiteabcellera.com
SymbolABCL
Key Statistics
General
Valuation Ratios
Profitability
Market Cap0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
People Also Bought
BB$3,39
+2,73%
AEG$7,06
+1,88%
XRAY$11,48
+1,95%
FDX$389,85
+9,47%
PAYO$4,63
+1,76%
LVS$55,00
+1,76%
ALGN$179,85
+2,04%
SFIX$3,37
+1,81%
SAVA$2,38
+12,26%
EXFY$0,84
+3,14%
AME$215,73
+2,00%
HLF$15,18
+1,95%
WMS$137,28
+1,95%
FLNA$1,87
+2,19%
CRL$156,03
+1,95%
BB$3,39
+2,73%
AEG$7,06
+1,88%
XRAY$11,48
+1,95%
FDX$389,85
+9,47%
PAYO$4,63
+1,76%
LVS$55,00
+1,76%
ALGN$179,85
+2,04%
SFIX$3,37
+1,81%
SAVA$2,38
+12,26%
EXFY$0,84
+3,14%
AME$215,73
+2,00%
HLF$15,18
+1,95%
WMS$137,28
+1,95%
FLNA$1,87
+2,19%
CRL$156,03
+1,95%
